Piskel Kyle's Form 4/A amendment
AmendedAdaptive Biotechnologies Corp (ADPT) · filed Nov 17, 2022
- Accession no.
- 0001209191-22-057531
- Filed
- Nov 17, 2022
- Trade date
- Nov 16, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Nov 17, 2022
This filing lists 1 non-derivative transaction. Open-market sales total $2.72K. It was filed 1 day after the trade.
This amendment replaces 0001209191-22-057432 (filed Nov 17, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Piskel KyleCIK 0001780662 | Officer (Principal Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2022 | Common Stock | SSaleDisposed | −307 | $8.87 | −$2,723.09 | 47,358 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding olbigaitons to e funded by a sell to cover transaction and does not represent a discretionary trade.